Pharmaceutical Company Selects a New 3PL to Cut Freight Costs and Strengthen Cold Chain Readiness
A pharmaceutical company distributing from the coasts engaged SPARQ360 to evaluate Midwest 3PLs against GMP, cold chain, and service standards and add a lower-cost distribution point.
The client, a pharmaceutical company distributing from Pennsylvania and California, wanted to add a Midwest distribution point to reduce freight cost. It needed a third-party logistics provider that could meet pharmaceutical standards, and it engaged SPARQ360 to run the evaluation.
The Challenge
The core problem was finding a 3PL that could handle pharmaceutical distribution to standard: good manufacturing practice (GMP), cold chain storage, quality systems, service levels, and readiness for 2026 volumes. Distribution ran only from Pennsylvania and California, which left freight costs higher than they needed to be for Midwest and central demand. The client wanted to add a distribution point without lowering the bar on compliance or service, and that balance is exactly where a rushed 3PL selection tends to go wrong.
The Strategy
SPARQ360 structured a focused evaluation of Midwest distribution centers. The slate deliberately included providers where the client already had a relationship and one where it did not, so the market was genuinely tested rather than defaulting to the familiar option. Adding a Midwest distribution center alongside the Pennsylvania and California operations was the lever to reduce freight cost, while pharmaceutical requirements stayed front and center in every comparison.
Related service: Supply Chain Optimization
Get in Touch
To see how SPARQ360 could help your team solve a similar challenge, talk to our team.
The Implementation
Over roughly two months, following an RFP the client began in the summer of 2025, SPARQ360 visited three Midwest distribution centers and brought healthcare best-in-class experience to the assessment. The team weighed each provider on GMP, storage and space, cold chain, quality, service levels, transportation, and the onboarding process. This engagement was carried by practitioner judgment rather than software; the value was in knowing what pharmaceutical distribution actually requires and holding each candidate against it.
The Results
The client selected the Memphis-based provider, driven by cost savings targeted for 2026 and a plan to vacate a higher-cost existing distribution center in the fourth quarter. That provider does not currently offer 2 to 8°C or minus 20°C storage and shipping, but committed to adding that capability in 2027. SPARQ360 and the client were aligned on the decision, on the condition that the cold chain capability lands on that timeline.
- New Midwest distribution point selected to reduce freight cost from coast-only distribution.
- Decision aligned to a 2026 cost-savings target and a Q4 exit from a higher-cost distribution center.
- Cold chain capability (2 to 8°C and minus 20°C) committed for 2027 as a condition of the selection.
Start Your Supply Chain Journey
SPARQ360 helps companies turn supply chain and sustainability challenges into measurable results. Contact SPARQ360 to start the conversation.
